Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hualian Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company is a leading global producer of steroid hormones, specializing in both active pharmaceutical ingredients (APIs) and finished dosage forms. Its extensive product portfolio includes essential medicines such as dexamethasone, prednisone, hydrocortisone, and mifepristone. With a history dating back to the Shanghai No. 2 Pharmaceutical Factory founded in 1939, the company operates multiple GMP-certified facilities and maintains a significant presence in international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Hualian Pharmaceutical.